14-3-3σ is required to prevent mitotic catastrophe after DNA damage (original) (raw)

Nature volume 401, pages 616–620 (1999)Cite this article

This article has been updated

Abstract

14-3-3σ is a member of a family of proteins that regulate cellular activity by binding and sequestering phosphorylated proteins. It has been suggested that 14-3-3σ promotes pre-mitotic cell-cycle arrest following DNA damage, and that its expression can be controlled by the p53 tumour suppressor gene1. Here we describe an improved approach to the generation of human somatic-cell knockouts, which we have used to generate human colorectal cancer cells in which both 14-3-3σ alleles are inactivated. After DNA damage, these cells initially arrested in the G2 phase of the cell cycle, but, unlike cells containing 14-3-3σ, the 14-3-3σ-/- cells were unable to maintain cell-cycle arrest. The 14-3-3σ-/- cells died (‘mitotic catastrophe’) as they entered mitosis. This process was associated with a failure of the 14-3-3σ-deficient cells to sequester the proteins (cyclin B1 and cdc2) that initiate mitosis and prevent them from entering the nucleus. These results may indicate a mechanism for maintaining the G2 checkpoint and preventing mitotic death.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Change history

A Correction to this paper has been published: https://doi.org/10.1038/s41586-023-06446-1

References

  1. Hermeking,H. et al. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1, 3–11 (1997).
    Article CAS PubMed Google Scholar
  2. Busler,D. E. & Li,S. W. Rapid screening of transgenic type II and type XI collagen knock-out mice with three-primer PCR. Biotechniques 6, 1002–1004 (1996).
    Article Google Scholar
  3. Waldman,T., Kinzler,K. W. & Vogelstein,B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55, 5187–5190 (1995).
    CAS PubMed Google Scholar
  4. Heald,R., McLoughlin,M. & McKeon,F. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase. Cell 74, 463–474 (1993).
    Article CAS PubMed Google Scholar
  5. Pines,J. Cell cycle: checkpoint on the nuclear frontier. Nature 397, 104–105 (1999).
    Article ADS CAS PubMed Google Scholar
  6. Nurse,P. Universal control mechanism regulating onset of M-phase. Nature 344, 503–508 (1990).
    Article ADS CAS PubMed Google Scholar
  7. Hagting,A., Karlsson,C., Clute,P., Jackman,M. & Pines,J. MPF localization is controlled by nuclear export. EMBO J. 17, 4127–4138 (1998).
    Article CAS PubMed PubMed Central Google Scholar
  8. Jin,P., Hardy,S. & Morgan,D. O. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141, 875–885 (1998).
    Article CAS PubMed PubMed Central Google Scholar
  9. Honda,R., Ohba,Y. & Yasuda,H. 14-3-3 zeta protein binds to the carboxyl half of mouse wee1 kinase. Biochem. Biophys. Res. Commun. 230, 262–265 (1997).
    Article CAS PubMed Google Scholar
  10. Peng,C. Y. et al. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501–1505 (1997).
    Article CAS PubMed Google Scholar
  11. Gardner,R., Putnam,C. W. & Weinert,T. RAD53, DUN1 and PDS1 define two parallel G2/M checkpoint pathways in budding yeast. EMBO J. 18, 3173–3185 (1999).
    Article CAS PubMed PubMed Central Google Scholar
  12. Toyoshima,F., Moriguchi,T., Wada,A., Fukuda,M. & Nishida,E. Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J. 17, 2728–2735 (1998).
    Article CAS PubMed PubMed Central Google Scholar
  13. Fukuda,M. et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature 390, 308–311 (1997).
    Article ADS CAS PubMed Google Scholar
  14. Fornerod,M., Ohno,M., Yoshida,M. & Mattaj,I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90, 1051–1060 (1997).
    Article CAS PubMed Google Scholar
  15. Lopez-Girona,A., Furnari,B., Mondesert,O. & Russell,P. Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397, 172–175 (1999).
    Article ADS CAS PubMed Google Scholar
  16. Waldman,T., Lengauer,C., Kinzler,K. W. & Vogelstein,B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713–716 (1996).
    Article ADS CAS PubMed Google Scholar
  17. Bunz,F. et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282, 1497–1501 (1998).
    Article CAS PubMed Google Scholar
  18. Reynisdottir,I., Polyak,K., Iavarone,A. & Massague,J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9, 1831–1845 (1995).
    Article CAS PubMed Google Scholar
  19. El-Deiry,W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
    Article CAS PubMed Google Scholar
  20. Nurse,P. Checkpoint pathways come of age. Cell 91, 865–867 (1997).
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

We thank the members of the Vogelstein/Kinzler Laboratory for helpful discussions. We thank M. Yoshida for the gift of leptomycin B and D. Tomasallo for helpful advice. Under an agreement between CalBiochem and Johns Hopkins University, K.W.K. and B.V. are entitled to a share of the sales royalty for the p21 antibody received by the University from CalBiochem. The terms of these arrangements are managed by the University in accordance with its conflict of interest policies. This work was supported by the Clayton Fund, the Medical Scientist Training Program and the NIH.

Author information

Authors and Affiliations

  1. The Johns Hopkins Oncology Center, Program in Human Genetics, and The Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, 424 N. Bond Street, Baltimore, 21231, Maryland, USA
    Timothy A. Chan, Heiko Hermeking, Christoph Lengauer, Kenneth W. Kinzler & Bert Vogelstein

Authors

  1. Timothy A. Chan
  2. Heiko Hermeking
  3. Christoph Lengauer
  4. Kenneth W. Kinzler
  5. Bert Vogelstein

Corresponding author

Correspondence toBert Vogelstein.

Rights and permissions

About this article

Cite this article

Chan, T., Hermeking, H., Lengauer, C. et al. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage.Nature 401, 616–620 (1999). https://doi.org/10.1038/44188

Download citation